PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 58.40
0.00 (0.00%)
Oct 23, 2026, 1:11 PM IDT
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 8.19 million as of October 23, 2026. It is the 47,138th most valuable company in the world and the 486th biggest in Israel. Its market cap has increased by 99.62% in one year.
ChartMarket Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 8.19M, a decrease of -97.51%. That is a compound annual growth rate of -50.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 8.19M | -16.30% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
| Jul 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.68B |
| Amal Holdings A.D. | 2.14B |
| Rafa Laboratories | 1.80B |
| BrainsWay | 1.46B |
| XTL Biopharmaceuticals | 19.87M |
| Can-Fite BioPharma | 18.39M |
| Evogene | 17.92M |
| MediPress Health-Limited Partnership | 7.81M |